清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Pan-cancer genomic analysis reveals FOXA1 amplification is associated with adverse outcomes in non-small cell lung, prostate, and breast cancers

福克斯A1 医学 肿瘤科 前列腺癌 乳腺癌 内科学 危险系数 癌症 转移性乳腺癌 癌症研究 置信区间
作者
Alexander G. Goglia,Mohammed Alshalalfa,Anwar Khan,Danielle Isakov,Helen Y. Hougen,Nishwant Swami,Jasmine Kannikal,Sean McBride,Daniel R. Gomez,Sanoj Punnen,Paul L. Nguyen,Puneeth Iyengar,Emmanuel S. Antonarakis,Brandon A. Mahal,Edward Christopher Dee
出处
期刊:Journal of the National Cancer Institute [Oxford University Press]
被引量:1
标识
DOI:10.1093/jnci/djae224
摘要

Abstract Introduction Alterations in forkhead box A1 (FOXA1), a pioneer transcription factor, are associated with poor prognosis in breast cancer (BC) and prostate cancer (PC). We characterized FOXA1 genomic alterations and their clinical impacts in a large pan-cancer cohort from the AACR GENIE database. Methods FOXA1 alterations were characterized across >87,000 samples from >30 cancer types for primary and metastatic tumors alongside patient characteristics and clinical outcomes. FOXA1 alterations were queried in the MSK-MET cohort (a GENIE subset), allowing definition of hazard ratios (HRs) and survival estimates based on Cox proportional hazard models. Results FOXA1 was altered in 1,869 samples (2.1%), with distinct patterns across different cancers: PC enriched with indel-inframe alterations, BC with missense mutations, and lung cancers with copy number (CN) amplifications. Of 74,715 samples with FOXA1 CN profiles, amplification was detected in 834 (1.1%). Amplification was most common in non-small cell lung cancer (NSCLC, 3% in primary; 6% in metastatic) and small cell lung cancer (4.1% primary; 3.5% metastatic), followed by BC (2% primary; 1.6% metastatic) and PC (2.2% primary; 1.6% metastatic). CN amplifications were associated with decreased overall survival in NSCLC (HR: 1.45, 95%CI: 1.06-1.99, p = .02), BC (HR: 3.04, 95%CI: 1.89-4.89, p = 4e−6), and PC (HR: 1.94, 95%CI: 1.03-3.68, p = .04). Amplifications were associated with wide-spread metastases in NSCLC, BC, and PC. Conclusions FOXA1 demonstrates distinct alteration profiles across cancer sites. Our findings suggest an association between FOXA1 amplification and both enhanced metastatic potential and decreased survival, highlighting prognostic and therapeutic potential in breast cancer, prostate cancer, and NSCLC.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
暴躁莹子发布了新的文献求助10
5秒前
AthurMarcus发布了新的文献求助30
8秒前
10秒前
含糊的青烟完成签到 ,获得积分10
13秒前
搞怪代荷发布了新的文献求助30
22秒前
SciGPT的应助被Fighter采纳,获得10
25秒前
悦耳乘风完成签到,获得积分10
26秒前
30秒前
Fighter发布了新的文献求助10
36秒前
37秒前
酷酷的海莲完成签到,获得积分10
51秒前
Aman完成签到,获得积分10
51秒前
Aman完成签到,获得积分10
55秒前
无极微光的应助被暴躁莹子采纳,获得20
1分钟前
暴躁莹子完成签到,获得积分10
1分钟前
kuaidi123完成签到 ,获得积分10
1分钟前
神勇友安完成签到,获得积分10
1分钟前
无私的碧玉完成签到,获得积分10
1分钟前
Maestro_S的应助被levosimendan采纳,获得10
1分钟前
烟花的应助被Fighter采纳,获得10
1分钟前
2分钟前
LINDENG2004完成签到 ,获得积分10
2分钟前
Fighter发布了新的文献求助10
2分钟前
芋圆完成签到 ,获得积分20
2分钟前
随心所欲完成签到 ,获得积分0
2分钟前
2分钟前
2分钟前
yc发布了新的文献求助10
2分钟前
2分钟前
成就云朵完成签到,获得积分10
2分钟前
Yolo完成签到 ,获得积分10
2分钟前
重要寄瑶完成签到,获得积分10
3分钟前
上官若男的应助被Fighter采纳,获得10
3分钟前
3分钟前
Fighter发布了新的文献求助10
3分钟前
科研通AI6.3的应助被amiee采纳,获得10
4分钟前
精明开山完成签到,获得积分10
4分钟前
4分钟前
Orange的应助被科研通管家采纳,获得10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190190
求助须知:如何正确求助?哪些是违规求助? 9577298
关于积分的说明 21852333
捐赠科研通 7788645
什么是DOI,文献DOI怎么找? 3436310
关于科研通互助平台的介绍 2560076
邀请新用户注册赠送积分活动 2482902